Inter-individual variability in neural response to low doses of LSD.
Nadia R P W Hutten, Conny W E M Quaedflieg, Natasha L Mason, Eef L Theunissen, Matthias E Liechti, Urs Duthaler, Kim P C Kuypers, Valerie Bonnelle, Amanda Feilding, Johannes G Ramaekers
Translational psychiatry July 15, 2024 DOI: 10.1038/s41398-024-03013-8 via PubMed
Summary
AI-generated from the abstractRepeated low doses of LSD (15 mcg) affect arousal, attention, and memory depending on a person's baseline cognitive state. In a randomized placebo-controlled trial with 53 healthy participants, LSD reduced resting-state EEG delta, theta, and alpha power (indicating stimulation) and enhanced pre-attentive processing during acute dosing sessions. LSD also blunted visual long-term potentiation (a marker of perceptual learning and memory) by the fourth dosing session. Stimulatory effects were strongest in individuals with low baseline arousal and attention, while inhibitory effects on memory were strongest in those with high baseline memory performance. Some EEG changes persisted at a one-week follow-up, suggesting possible neuroadaptations from repeated low-dose LSD.
Study at a glance
| Characteristics | Randomized controlled trial Placebo-controlled Peer reviewed |
|---|---|
| Sample size | 53 |
| Population | Healthy participants |
| Intervention | LSD |
| Dose | 15 mcg |
| Duration | 2-week treatment period with 4 dosing sessions, plus baseline and 1-week follow-up visits |
| Topics | Microdosing |
| Keywords | Cognitive enhancement Psychedelics Neuroscience Mental health |
| Citations | 16 |
| Key finding | Acute responses to low doses of LSD depend on an individual's baseline cognitive state, with stimulatory effects strongest in those with low arousal and attention and inhibitory effects strongest in high memory performers. |
Abstract
The repeated use of small doses of psychedelics (also referred to as "microdosing") to facilitate benefits in mental health, cognition, and mood is a trending practice. Placebo-controlled studies however have largely failed to demonstrate strong benefits, possibly because of large inter-individual response variability. The current study tested the hypothesis that effects of low doses of LSD on arousal, attention and memory depend on an individual's cognitive state at baseline. Healthy participants (N = 53) were randomly assigned to receive repeated doses of LSD (15 mcg) or placebo on 4 occasions divided over 2 weeks. Each treatment condition also consisted of a baseline and a 1-week follow-up visit. Neurophysiological measures of arousal (resting state EEG), pre-attentive processing (auditory oddball task), and perceptual learning and memory (visual long-term potentiation (LTP) paradigm) were assessed at baseline, dosing session 1 and 4, and follow-up. LSD produced stimulatory effects as reflected by a reduction in resting state EEG delta, theta, and alpha power, and enhanced pre-attentive processing during the acute dosing sessions. LSD also blunted the induction of LTP on dosing session 4. Stimulatory effects of LSD were strongest in individuals with low arousal and attention at baseline, while inhibitory effects were strongest in high memory performers at baseline. Decrements in delta EEG power and enhanced pre-attentive processing in the LSD treatment condition were still present during the 1-week follow-up. The current study demonstrates across three cognitive domains, that acute responses to low doses of LSD depend on the baseline state and provides some support for LSD induced neuroadaptations that sustain beyond treatment.